T-DM1 Clinical Trials
3 recruitingDrug
Phase 22Phase 32
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.1,450 enrolled2 locationsNCT06830889
Recruiting
Phase 2
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
Breast CancerBreast Cancer MetastaticBreast Cancer Female+3 more
Dana-Farber Cancer Institute72 enrolled1 locationNCT06439693
Recruiting
Phase 2Phase 3
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
Breast CancerBreast Cancer Stage IBreast Cancer Stage II+1 more
University of Virginia45 enrolled1 locationNCT05288777